These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23870533)

  • 1. Subversion of trafficking, apoptosis, and innate immunity by type III secretion system effectors.
    Raymond B; Young JC; Pallett M; Endres RG; Clements A; Frankel G
    Trends Microbiol; 2013 Aug; 21(8):430-41. PubMed ID: 23870533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the Inflammasome Signaling Pathway by Enteropathogenic and Enterohemorrhagic Escherichia coli.
    Yen H; Karino M; Tobe T
    Front Cell Infect Microbiol; 2016; 6():89. PubMed ID: 27617233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host Cell Targeting by Enteropathogenic Bacteria T3SS Effectors.
    Pinaud L; Sansonetti PJ; Phalipon A
    Trends Microbiol; 2018 Apr; 26(4):266-283. PubMed ID: 29477730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector-mediated subversion of host innate immune pathways.
    Santos AS; Finlay BB
    Cell Microbiol; 2015 Mar; 17(3):318-32. PubMed ID: 25588886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vying for the control of inflammasomes: The cytosolic frontier of enteric bacterial pathogen-host interactions.
    Sanchez-Garrido J; Slater SL; Clements A; Shenoy AR; Frankel G
    Cell Microbiol; 2020 Apr; 22(4):e13184. PubMed ID: 32185892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The
    Schubert KA; Xu Y; Shao F; Auerbuch V
    Annu Rev Microbiol; 2020 Sep; 74():221-245. PubMed ID: 32660389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T3SS-Independent Uptake of the Short-Trip Toxin-Related Recombinant NleC Effector of Enteropathogenic
    Stolle AS; Norkowski S; Körner B; Schmitz J; Lüken L; Frankenberg M; Rüter C; Schmidt MA
    Front Cell Infect Microbiol; 2017; 7():119. PubMed ID: 28451521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammasomes, Autophagy, and Cell Death: The Trinity of Innate Host Defense against Intracellular Bacteria.
    Krakauer T
    Mediators Inflamm; 2019; 2019():2471215. PubMed ID: 30728749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of host signaling in the inflammatory response by enteropathogenic Escherichia coli virulence proteins.
    Zhuang X; Chen Z; He C; Wang L; Zhou R; Yan D; Ge B
    Cell Mol Immunol; 2017 Mar; 14(3):237-244. PubMed ID: 27796284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammasome activation in response to the Yersinia type III secretion system requires hyperinjection of translocon proteins YopB and YopD.
    Zwack EE; Snyder AG; Wynosky-Dolfi MA; Ruthel G; Philip NH; Marketon MM; Francis MS; Bliska JB; Brodsky IE
    mBio; 2015 Feb; 6(1):e02095-14. PubMed ID: 25691590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attaching and effacing pathogens: the effector ABC of immune subversion.
    Riebisch AK; Mühlen S
    Future Microbiol; 2020 Jul; 15():945-958. PubMed ID: 32716209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmonella, E. coli, and Citrobacter Type III Secretion System Effector Proteins that Alter Host Innate Immunity.
    El Qaidi S; Wu M; Zhu C; Hardwidge PR
    Adv Exp Med Biol; 2019; 1111():205-218. PubMed ID: 30411307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shigella IpaH Family Effectors as a Versatile Model for Studying Pathogenic Bacteria.
    Ashida H; Sasakawa C
    Front Cell Infect Microbiol; 2015; 5():100. PubMed ID: 26779450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of innate immune responses by Yersinia type III secretion system translocators and effectors.
    Bliska JB; Wang X; Viboud GI; Brodsky IE
    Cell Microbiol; 2013 Oct; 15(10):1622-31. PubMed ID: 23834311
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Brunner K; Samassa F; Sansonetti PJ; Phalipon A
    Hum Vaccin Immunother; 2019; 15(6):1317-1325. PubMed ID: 30964713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function.
    Gao X; Wan F; Mateo K; Callegari E; Wang D; Deng W; Puente J; Li F; Chaussee MS; Finlay BB; Lenardo MJ; Hardwidge PR
    PLoS Pathog; 2009 Dec; 5(12):e1000708. PubMed ID: 20041225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperative Immune Suppression by Escherichia coli and Shigella Effector Proteins.
    de Jong MF; Alto NM
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29339461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Yersinia effector with enhanced inhibitory activity on the NF-κB pathway activates the NLRP3/ASC/caspase-1 inflammasome in macrophages.
    Zheng Y; Lilo S; Brodsky IE; Zhang Y; Medzhitov R; Marcu KB; Bliska JB
    PLoS Pathog; 2011 Apr; 7(4):e1002026. PubMed ID: 21533069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staying out or Going in? The Interplay between Type 3 and Type 5 Secretion Systems in Adhesion and Invasion of Enterobacterial Pathogens.
    Whelan R; McVicker G; Leo JC
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32521829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RIPK1-dependent apoptosis bypasses pathogen blockade of innate signaling to promote immune defense.
    Peterson LW; Philip NH; DeLaney A; Wynosky-Dolfi MA; Asklof K; Gray F; Choa R; Bjanes E; Buza EL; Hu B; Dillon CP; Green DR; Berger SB; Gough PJ; Bertin J; Brodsky IE
    J Exp Med; 2017 Nov; 214(11):3171-3182. PubMed ID: 28855241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.